CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 560 enrolled
Drug / intervention
Acoustic paradigmsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06520865
NCT06520865N/ACompleted

Identification and Validation of a Biomarker for Tinnitus: an Objective Data-driven Personalized Approach to Diagnosis of Chronic Tinnitus - The Tinnitus Detection (TIDE) Project

University of Regensburg·observational·Posted Jul 25, 2024·Updated Mar 24, 2026

In Brief

An observational study evaluating Acoustic paradigms for Tinnitus. Completed, enrolled 560 participants across 7 sites in 5 countries.

Detailed Summary

Research in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinnitus, the clinical management of tinnitus remains largely based on a 'trial and error' approach. The identification and validation of a biomarker for tinnitus is thought to be the crucial step in the development of a personalized approach to the diagnosis and treatment of tinnitus. The overarching goal of this study is to incorporate advanced technologies to provide an objective, data-driven, personalized approach to the diagnosis of chronic tinnitus. This should lead to a clinically applicable tool that can be widely and easily used.

Study Details

Timeline

N/ACompletedFinished
20252026
First PostedJul 25, 2024
Enrollment StartAug 1, 2024
Primary CompletionNov 30, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 1.9 years ago

Interventions

Acoustic paradigmsother

Acoustic oddball Gap detection